Summary
Five healthy men were given 1.0 mg methysergide maleate intravenously and 2.7 mg methysergide maleate orally in a cross-over study.
The systemic availability of methysergide was only 13%, most probably due to a high degree of first-pass metabolism to methylergometrine. We also found evidence of extrahepatic clearance of methysergide.
After oral administration the plasma concentrations of the metabolite were considerably higher than those of the parent drug and the area under the plasma concentration curve (AUC) for methylergometrine was more than ten times greater than for methysergide.
Our findings may be relevant to the treatment of migraine if methylergometrine contributes to the effect of methysergide.
Methylergometrine had a significantly longer elimination half-life than methysergide (223±43 min vs 62.0±8.3 min and 174±35 min vs 44.8±8.1 min in the oral and intravenous studies respectively).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berde B, Stürmer E (1978) Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO (eds) Ergotalkaloids and related compounds. Springer, Berlin Heidelberg New York, pp 2–4
Meier J, Schreier E (1976) Human plasma levels of some antimigraine drugs. Headache 16: 96–104
Bianchine JR, Friedman AP (1970) Metabolism of methysergide and retroperitoneal fibrosis. Arch Intern Med 126: 252–254
Edlund PO (1981) Determination of ergotalkaloids in biological samples by high performance liquid chromatography and fluorescence detection. J Chromatogr 226: 107–115
Pang KS (1981) The area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites. J Pharmacokinet Biopharm 9: 477–487
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bredberg, U., Eyjolfsdottir, G.S., Paalzow, L. et al. Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharmacol 30, 75–77 (1986). https://doi.org/10.1007/BF00614199
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00614199